NOVOFEMME, film-coated tablet 16 tablets
Active ingredients: (17R)-norethindrone acetate, 17β-estradiol, Estradiol hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOVOFEMME, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 boîte(s) avec distributeur(s) polypropylène polystyrène de 16 comprimé(s) rouges et de 12 comprimé(s) blancs
- Marketing authorisation holder
- NOVO NORDISK
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68778431CIP73584792CIP133400935847928Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESTRADIOL ANHYDREcomprimé blanc | 1 mg · un comprimé | FT |
| ACÉTATE DE NORÉTHISTÉRONEcomprimé blanc | 1 mg · un comprimé | SA |
| ESTRADIOL HÉMIHYDRATÉcomprimé blanc | — | SA |
| ESTRADIOL ANHYDREcomprimé rouge | 1 mg · un comprimé | FT |
| ESTRADIOL HÉMIHYDRATÉcomprimé rouge | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.